The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

DuPont Reports Q2 Operating Earnings Per Share of $1.17; Reaffirms Updated Full-Year Outlook

Tuesday, July 22, 2014

DuPont Reports Q2 Operating Earnings Per Share of $1.17; Reaffirms Updated Full-Year Outlook

06:00 EDT Tuesday, July 22, 2014

WILMINGTON, Del., July 22, 2014 /PRNewswire/ --

Second Quarter Highlights

  • Operating earnings per share of $1.17 were down moderately from $1.28 per share last year, in-line with the company's expectations communicated in its June 26th announcement. GAAP1 earnings per share were $1.15 versus $1.10 last year.
  • Revenue was $9.7 billion versus $9.8 billion in the same period last year. Volume growth in Crop Protection, Nutrition & Health and most industrial businesses was offset by the impact of portfolio changes, a planned maintenance shutdown and lower corn seed volumes.
  • Strong operating earnings growth in the quarter was delivered by Industrial Biosciences (+37 percent), Nutrition & Health (+72 percent) and Safety & Protection (+22 percent).
  • The strategic redesign initiative announced on June 26th to reset the company's operating model is under way across all businesses and support functions.
  • The Performance Chemicals separation remains on track for mid-2015.
  • The company also announced today a 4 percent increase in its 3Q 2014 dividend, its third increase in the past 27 months.

DuPont (NYSE: DD), a science company that brings world-class, innovative products, materials and services to the global marketplace, today announced second quarter 2014 operating earnings of $1.17 per share compared to $1.28 per share in the prior year.  GAAP1 earnings per share were $1.15 versus $1.10 last year.  Consolidated sales were $9.7 billion, 1 percent below last year, reflecting portfolio changes, as price, volume and currency were in line with the prior year period. 

"While lower Agriculture earnings impacted our results this quarter, we continue to see strong science-driven growth in this segment over the long term.  We are steadily advancing DuPont's strategy to build and strengthen world-leading positions in agriculture and nutrition, bio-based industrials and advanced materials," said DuPont Chair and CEO Ellen Kullman.  "As we move ahead with our Performance Chemicals separation, we also have launched the initial stage of a broad initiative to reset our operating model.  This work is already gaining traction and will continue to expand, positioning DuPont to drive greater growth and value with a simplified, streamlined support structure and a smaller cost base - consistent with the purpose, strategy and needs of the DuPont company, post-separation."

Global Consolidated Net Sales ? 2nd Quarter

Second quarter 2014 net sales of $9.7 billion were 1 percent below last year due to portfolio changes.   Volume and USD prices were flat.  The table below shows second quarter regional sales and variances versus second quarter 2013.

Three Months Ended June 30, 2014

Percentage Change Due to:

(Dollars in millions)

$

%Change

Local  Price

Currency Effect

Volume

Portfolio/ Other

U.S. & Canada

$    4,603

(3)

-

(1)

-

(2)

EMEA*

2,119

2

(1)

4

(1)

-

Asia Pacific

2,089

-

(2)

(2)

5

(1)

Latin America

895

(4)

1

(2)

(2)

(1)

Total Consolidated Sales

$    9,706

(1)

-

-

-

(1)

* Europe, Middle East & Africa

Segment Sales ? 2nd Quarter

The table below shows second quarter 2014 segment sales with related variances versus second quarter 2013.

SEGMENT SALES

Three Months Ended

Percentage Change 

(Dollars in millions)

June 30, 2014

Due to:

$

% Change

USD Price

Volume

Portfolio/Other

Agriculture

$      3,615

-

1

(1)

-

Electronics & Communications 

617

(6)

(10)

4

-

Industrial Biosciences

317

4

2

2

-

Nutrition & Health

926

7

1

6

-

Performance Chemicals

1,696

(8)

(4)

-

(4)

Performance Materials

1,582

(2)

1

(1)

(2)

Safety & Protection

1,029

1

-

1

-

Other

1

Total segment sales

9,783

Elimination of transfers

(77)

Consolidated net sales

$      9,706

Operating Earnings ? 2nd Quarter

 Change vs. 2013 

(Dollars in millions)

2Q14

2Q13

$

%

Agriculture 

$      836

$     941

$  (105)

-11%

Electronics & Communications

89

95

(6)

-6%

Industrial Biosciences

59

43

16

37%

Nutrition & Health

105

61

44

72%

Performance Chemicals (1)

251

268

(17)

-6%

Performance Materials (1)

303

332

(29)

-9%

Safety & Protection

209

172

37

22%

Other

(82)

(55)

(27)

-49%

Total segment operating earnings (2)

1,770

1,857

(87)

-5%

Exchange gains & losses (3)

(51)

35

(86)

nm

Corporate expenses

(186)

(195)

9

5%

Interest expense

(94)

(115)

21

18%

Operating earnings before income taxes 

1,439

1,582

(143)

-9%

Provision for income taxes on operating earnings       

(350)

(389)

39

nm

Net income attributable to noncontrolling interests

(4)

(4)

-

-

Operating earnings  

$  1,085

$  1,189

$  (104)

-9%

Operating earnings per share

$     1.17

$    1.28

$ (0.11)

-9%

(1)  Prior period reflects the reclassifications of the Viton®product line from Performance Materials to Performance Chemicals.

(2)  See Schedules B and C for listing of significant items and their impact by segment.  

(3)  See Schedule D for additional information on exchange gains and losses.

The following is a summary of business results for each of the company's reportable segments in the second quarter which compares the current period with the prior year.  References to selling price are on a U.S. dollar basis, including the impact of currency.

Agriculture ? Operating earnings of $836 million declined $105 million, or 11 percent, on lower corn seed volumes, lower North America herbicide volumes and higher seed inventory write-downs.  This was partially offset by higher seed prices, higher insecticide volumes, higher soybean volumes and lower seed input costs.

Electronics & Communications ? Operating earnings of $89 million declined $6 million, or 6 percent.  Sales volumes grew in consumer electronics and operating earnings benefited from productivity improvements.  However, the prior year included $20 million of OLED licensing income. 

Industrial Biosciences ? Operating earnings of $59 million increased $16 million, or 37 percent, from continued strong enzyme demand for animal nutrition, food and ethanol production.  This was partially offset by lower sales for Sorona® polymer for carpeting.

Nutrition & Health ? Operating earnings of $105 million increased $44 million, or 72 percent, from broad based volume growth and improved mix, lower raw material costs, productivity gains and the absence of one-time costs in the prior year.

Performance Chemicals ? Operating earnings of $251 million were down $17 million, or 6 percent, due primarily to lower prices for refrigerants and fluoropolymers, partially offset by productivity improvements.

Performance Materials ? Operating earnings of $303 million decreased $29 million, or 9 percent.  Gains from strong Performance Polymers volumes into global automotive markets were offset by a scheduled maintenance shutdown at the company's Orange, Texas ethylene unit.  Absent that shutdown, segment operating earnings would have increased. 

Safety & Protection ? Operating earnings of $209 million increased $37 million, or 22 percent, primarily due to higher volumes in Protection Technologies, lower product costs and productivity improvements.

Outlook

The company reaffirms its recently updated outlook for full-year 2014 operating earnings of $4.00-$4.10 per share, an increase of 3 to 6 percent from $3.88 per share earned in 2013, based on expected growth in global industrial market demand.  The company anticipates a strong second half in 2014 with operating earnings per share of $1.25 - $1.35, about 40 percent of which is expected in the third quarter.  

DuPont will hold a conference call and webcast on Tuesday, July 22, 2014, at 9:00 AM EDT to discuss this news release.  The webcast can be accessed by visiting the company's investor website (Events & Presentations) at www.investors.dupont.com.  A replay of the conference call webcast will be available for 30 days by calling 1-630-652-3042, Passcode 37666079#.  For additional information see the investor center at http://www.dupont.com.

Use of Non-GAAP Measures

Management believes that certain non-GAAP measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company.  Such measurements are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance.  Reconciliations of non-GAAP measures to GAAP are provided in schedules A, C and D.

About DuPont

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements:  This news release contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "believes," "intends," "estimates," "anticipates" or other words of similar meaning.  All statements that address expectations or projections about the future, including statements about the company's growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements.  Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized.  Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control.  Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; ability to protect and enforce the company's intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff.  The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

 

E.I. du Pont de Nemours and Company

Consolidated Income Statements

(Dollars in millions, except per share amounts)

SCHEDULE A

Three Months Ended

June 30,

Six Months Ended

June 30,

2014

2013

2014

2013

Net sales

$

9,706

$

9,844

$

19,834

$

20,252

Other income, net (a)

408

159

425

251

Total

10,114

10,003

20,259

20,503

Cost of goods sold

5,999

6,056

11,999

12,249

Other operating charges (a)

825

942

1,622

1,854

Selling, general and administrative expenses

948

983

1,873

1,966

Research and development expense

545

542

1,063

1,063

Interest expense

94

115

197

232

Employee separation and asset related charges (a)

263

?

263

?

Total

8,674

8,638

17,017

17,364

Income from continuing operations before income taxes

1,440

1,365

3,242

3,139

Provision for income taxes on continuing operations (a)

366

335

723

722

Income from continuing operations after income taxes

1,074

1,030

2,519

2,417

Income from discontinued operations after taxes

?

4

?

1,972

Net income

1,074

1,034

2,519

4,389

Less:  Net income attributable to noncontrolling interests

4

4

10

11

Net income attributable to DuPont

$

1,070

$

1,030

$

2,509

$

4,378

Basic earnings per share of common stock (b):

Basic earnings per share of common stock from continuing operations

$

1.16

$

1.11

$

2.72

$

2.59

Basic earnings per share of common stock from discontinued operations

?

?

?

2.13

Basic earnings per share of common stock

$

1.16

$

1.11

$

2.72

$

4.73

Diluted earnings per share of common stock (b):

Diluted earnings per share of common stock from continuing operations

$

1.15

$

1.10

$

2.70

$

2.58

Diluted earnings per share of common stock from discontinued operations

?

?

?

2.12

Diluted earnings per share of common stock

$

1.15

$

1.11

$

2.70

$

4.69

Dividends per share of common stock

$

0.45

$

0.45

$

0.90

$

0.88

Average number of shares outstanding used in earnings per share (EPS) calculation:

  Basic

918,684,000

922,684,000

921,058,000

925,500,000

  Diluted

925,587,000

929,480,000

928,145,000

932,311,000

(a) See Schedule B for detail of significant items.

(b) The sum of the individual earnings per share amounts may not equal the total due to rounding.

Reconciliation of Non-GAAP Measures

Summary of Earnings Comparison

Three Months Ended

June 30,

Six Months Ended

June 30,

2014

2013

%

Change

2014

2013

%

Change

Income from continuing operations after income taxes (GAAP)

$

1,074

$

1,030

4 %

$

2,519

$

2,417

4 %

Less: Significant items benefit (charge) included in income from continuing

       operations after income taxes (per Schedule B)

8

(78)

(4)

(58)

Non-operating pension/OPEB costs included in income from continuing

    operations after income taxes

(23)

(85)

(44)

(184)

Net income attributable to noncontrolling interest

4

4

10

11

Operating earnings

$

1,085

$

1,189

(9)%

$

2,557

$

2,648

(3)%

EPS from continuing operations (GAAP)

$

1.15

$

1.10

5 %

$

2.70

$

2.58

5 %

Significant items (charge) benefit included in EPS (per Schedule B)

0.01

(0.08)

?

(0.06)

Non-operating pension/OPEB costs included in EPS

(0.03)

(0.10)

(0.05)

(0.20)

Operating EPS

$

1.17

$

1.28

(9)%

$

2.75

$

2.84

(3)%

 

E.I. du Pont de Nemours and Company

Condensed Consolidated Balance Sheets

(Dollars in millions, except per share amounts)

Schedule A (continued)

June 30,

2014

December 31,

2013

Assets

Current assets

Cash and cash equivalents

$

4,174

$

8,941

Marketable securities

173

145

Accounts and notes receivable, net

8,896

6,047

Inventories

6,940

8,042

Prepaid expenses

252

206

Deferred income taxes

894

775

Assets held for sale

?

228

Total current assets

21,329

24,384

Property, plant and equipment, net of accumulated depreciation

   (June 30, 2014- $19,961; December 31, 2013 - $19,438)

13,035

12,993

Goodwill

4,686

4,713

Other intangible assets

4,885

5,096

Investment in affiliates

982

1,011

Deferred income taxes

2,420

2,353

Other assets

977

949

Total

$

48,314

$

51,499

Liabilities and Equity

Current liabilities

Accounts payable

$

3,542

$

5,180

Short-term borrowings and capital lease obligations

2,506

1,721

Income taxes

763

247

Other accrued liabilities

4,228

6,219

Total current liabilities

11,039

13,367

Long-term borrowings and capital lease obligations

9,292

10,741

Other liabilities

9,931

10,179

Deferred income taxes

924

926

Total liabilities

31,186

35,213

Commitments and contingent liabilities

?

?

Stockholders' equity

Preferred stock

237

237

Common stock, $0.30 par value; 1,800,000,000 shares authorized;

   Issued at June 30, 2014 - 1,003,546,000; December 31, 2013 - 1,014,027,000)

301

304

Additional paid-in capital

11,168

11,072

Reinvested earnings

17,572

16,784

Accumulated other comprehensive loss

(5,453)

(5,441)

Common stock held in treasury, at cost (87,584,000 shares at June 30, 2014 and 87,041,000 shares at December 31, 2013)

(6,762)

(6,727)

Total DuPont stockholders' equity

17,063

16,229

Noncontrolling interests

65

57

Total equity

17,128

16,286

Total

$

48,314

$

51,499

E.I. du Pont de Nemours and Company

Condensed Consolidated Statement of Cash Flows

(Dollars in millions)

SCHEDULE A (continued)

Six Months Ended

June 30,

2014

2013

Total Company

Net income

$

2,519

$

4,389

Adjustments to reconcile net income to cash used for operating activities:

Depreciation

635

644

Amortization

245

193

Other operating charges and credits - net

631

185

Gain on sale of business

(398)

(2,682)

Contributions to pension plans

(168)

(176)

Change in operating assets and liabilities - net

(5,535)

(5,184)

Cash used for operating activities

(2,071)

(2,631)

Investing activities

Purchases of property, plant and equipment

(781)

(757)

Investments in affiliates

(23)

(31)

Proceeds from sale of business - net

639

4,815

Proceeds from sales of assets - net

10

88

Net increase in short-term financial instruments

(22)

(99)

Forward exchange contract settlements

(63)

58

Other investing activities - net

8

8

Cash (used for) provided by investing activities

(232)

4,082

Financing activities

Dividends paid to stockholders

(836)

(823)

Net (decrease) increase in borrowings

(631)

2,369

Repurchase of common stock

(1,061)

(1,000)

Proceeds from exercise of stock options

214

384

Other financing activities - net

(76)

74

Cash (used for) provided by financing activities

(2,390)

1,004

Effect of exchange rate changes on cash

(74)

(149)

(Decrease) increase in cash and cash equivalents

(4,767)

2,306

Cash and cash equivalents at beginning of period

8,941

4,379

Cash and cash equivalents at end of period

$

4,174

$

6,685

Reconciliation of Non-GAAP Measure

Calculation of Free Cash Flow - Total Company

Six Months Ended

June 30,

2014

2013

Cash used for operating activities

$

(2,071)

$

(2,631)

Purchases of property, plant and equipment

(781)

(757)

Free cash flow

$

(2,852)

$

(3,388)

 

E.I. du Pont de Nemours and Company

Schedule of Significant Items from Continuing Operations

(Dollars in millions, except per share amounts)

SCHEDULE B

SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS

Pre-tax

After-tax

($ Per Share)

2014

2013

2014

2013

2014

2013

1st Quarter

Separation transaction costs (a)

$

(16)

$

?

$

(12)

$

?

$

(0.01)

$

?

Customer claims charge (e)

?

(35)

?

(22)

?

(0.02)

Income tax items (f)

?

?

?

42

?

0.04

1st Quarter - Total

$

(16)

$

(35)

$

(12)

$

20

$

(0.01)

$

0.02

2nd Quarter

Separation transaction costs (a)

$

(35)

$

?

$

(26)

$

?

$

(0.03)

$

?

Gain on sale of business (b)

391

?

273

?

0.30

?

Restructuring charge (c)

(263)

?

(182)

?

(0.20)

?

Venezuela devaluation (d)

(58)

?

(57)

?

(0.06)

?

Customer claims charge (e)

?

(80)

?

(51)

?

(0.05)

Income tax items (g)

?

(11)

?

(27)

?

(0.03)

2nd Quarter - Total

$

35

$

(91)

$

8

$

(78)

$

0.01

$

(0.08)

Year-to-date Total

$

19

$

(126)

$

(4)

$

(58)

$

?

$

(0.06)

(a)

Second and first quarter 2014 included a charge of $(35) and $(16), respectively, recorded in Other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment.  For full-year 2014, costs associated with the separation are expected to be approximately $(170), $(0.13) per share.

(b)

Second quarter 2014 included a gain of $391 recorded in Other income, net associated with the sale of Glass Laminating Solutions/Vinyls in the Performance Materials segment.

(c)

Second quarter 2014 included a $(263) restructuring charge recorded in Employee separation/asset related charges, net, consisting of $(166) of severance and related benefit costs, $(94) of asset shut downs, and $(3) of other non-personnel charges as a result of the company's plan to reduce residual costs associated with the separation of the Performance Chemicals segment and to improve productivity across all businesses and functions.  Pre-tax charges by segment are: Agriculture - $(47), Electronics & Communications - $(68), Industrial Biosciences - $(2), Nutrition & Health - $(8), Performance Chemicals - $(19), Performance Materials - $(29), Safety & Protection - $(31), Other - $(2), and Corporate expenses - $(57).

(d)

Second quarter 2014 included a charge of $(58) recorded in Other income, net associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system.

(e)

Second and first quarter 2013 included charges of $(80) and $(35), respectively, recorded in Other operating charges associated with resolving claims related to the use of the Imprelis® herbicide.  The company has an applicable insurance program with a deductible equal to the first $100 of costs and expenses.  The insurance program limits are $725 for costs and expenses in excess of the $100.  The company has submitted and will continue to submit requests for payment to its insurance carriers for costs associated with this matter. To date, the company has recognized and received $73 of insurance recoveries from its insurance carriers and continues to seek recovery although the timing and outcome remain uncertain.  The company had accruals of $364 related to these claims at June 30, 2014.  These charges relate to the Agriculture segment.

(f)

First quarter 2013 included a net tax benefit of $42 consisting of a $68 benefit for the 2013 extension of certain U.S business tax provisions offset by a ($26) charge related to the global distribution of Performance Coatings cash proceeds.

(g)

Second quarter 2013 includes a charge of $(11) in Other income, net related to interest on a prior year tax position. Second quarter 2013 also includes a charge of $(49) associated with a change in accrual for a prior year tax position offset by a $33 benefit for an enacted tax law change.

E.I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)

SCHEDULE C

Three Months Ended

June 30,

Six Months Ended

June 30,

SEGMENT SALES (1)

2014

2013

2014

2013

Agriculture

$

3,615

$

3,631

$

8,009

$

8,300

Electronics & Communications

617

653

1,197

1,269

Industrial Biosciences

317

304

618

593

Nutrition & Health

926

865

1,787

1,733

Performance Chemicals (2)

1,696

1,837

3,287

3,480

Performance Materials (2)

1,582

1,615

3,116

3,116

Safety & Protection

1,029

1,017

1,976

1,924

Other

1

3

2

4

Total Segment sales

9,783

9,925

19,992

20,419

Elimination of transfers

(77)

(81)

(158)

(167)

Consolidated net sales

$

9,706

$

9,844

$

19,834

$

20,252

(1)  Sales for the reporting segments include transfers.

(2)  Prior periods reflect the reclassifications of the Viton® product line from Performance Materials to Performance

     Chemicals.

E.I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)

SCHEDULE C (continued)

Three Months Ended

June 30,

Six Months Ended

June 30,

INCOME FROM CONTINUING OPERATIONS (GAAP)

2014

2013

2014

2013

Agriculture

$

789

$

861

$

2,231

$

2,342

Electronics & Communications

21

95

96

144

Industrial Biosciences

57

43

113

84

Nutrition & Health

97

61

190

137

Performance Chemicals (3)

232

268

438

524

Performance Materials (3)

665

332

958

619

Safety & Protection

178

172

353

310

Other

(84)

(55)

(176)

(142)

Total Segment PTOI

1,955

1,777

4,203

4,018

Corporate expenses

(278)

(206)

(495)

(420)

Interest expense

(94)

(115)

(197)

(232)

Non-operating pension/OPEB costs

(34)

(126)

(64)

(273)

Net exchange (losses) gains (1)

(109)

35

(205)

46

Income before income taxes from continuing operations

$

1,440

$

1,365

$

3,242

$

3,139

Three Months Ended

June 30,

Six Months Ended

June 30,

SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (2)

2014

2013

2014

2013

Agriculture

$

(47)

$

(80)

$

(47)

$

(115)

Electronics & Communications

(68)

?

(68)

?

Industrial Biosciences

(2)

?

(2)

?

Nutrition & Health

(8)

?

(8)

?

Performance Chemicals (3)

(19)

?

(19)

?

Performance Materials (3)

362

?

362

?

Safety & Protection

(31)

?

(31)

?

Other

(2)

?

(2)

?

Total significant items by segment

185

(80)

185

(115)

Corporate expenses

(92)

(11)

(108)

(11)

Net exchange (losses) gains (1)

(58)

?

(58)

?

Total significant items before income taxes

$

35

$

(91)

$

19

$

(126)

Three Months Ended

June 30,

Six Months Ended

June 30,

OPERATING EARNINGS

2014

2013

2014

2013

Agriculture

$

836

$

941

$

2,278

$

2,457

Electronics & Communications

89

95

164

144

Industrial Biosciences

59

43

115

84

Nutrition & Health

105

61

198

137

Performance Chemicals (3)

251

268

457

524

Performance Materials (3)

303

332

596

619

Safety & Protection

209

172

384

310

Other

(82)

(55)

(174)

(142)

Total segment operating earnings

1,770

1,857

4,018

4,133

Corporate expenses

(186)

(195)

(387)

(409)

Interest expense

(94)

(115)

(197)

(232)

Operating earnings before income taxes and exchange gains (losses)

1,490

1,547

3,434

3,492

Net exchange (losses) gains (1)

(51)

35

(147)

46

Operating earnings before income taxes

$

1,439

$

1,582

$

3,287

$

3,538

(1)  See Schedule D for additional information on exchange gains and losses.

(2)  See Schedule B for detail of significant items.

(3)  Prior periods reflect the reclassifications of the Viton® product line from Performance Materials to Performance Chemicals.

E.I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions, except per share amounts)

SCHEDULE D

Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements

Three Months Ended

June 30,

Six Months Ended

June 30,

2014

2013

2014

2013

Income from continuing operations before income taxes

$

1,440

$

1,365

$

3,242

$

3,139

Add: Significant items before income taxes

(35)

91

(19)

126

Add: Non-operating pension/OPEB costs

34

126

64

273

Operating earnings before income taxes

$

1,439

$

1,582

$

3,287

$

3,538

Less: Net income attributable to noncontrolling interests

4

4

10

11

Add:  Interest expense

94

115

197

232

Adjusted EBIT from operating earnings

1,529

1,693

3,474

3,759

Add: Depreciation and amortization

443

404

880

837

Adjusted EBITDA from operating earnings

$

1,972

$

2,097

$

4,354

$

4,596

Reconciliation of Operating Earnings Per Share (EPS) Outlook

The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings from continuing operations excluding significant items and non-operating pension/OPEB costs.

Second Half

Year Ended December 31,

2014 Outlook

2014 Outlook

2013 Actual

Operating EPS

$1.25 - $1.35

 $4.00 - $4.10

$

3.88

Significant items

Separation transaction costs

(0.09)

(0.13)

Gain on sale of business

0.30

Restructuring charge

(0.20)

Venezuela devaluation

(0.06)

Tax items

0.02

Customer claims charges

(0.24)

Restructuring charge/adjustments

?

Litigation settlement

(0.05)

Asset impairment charge

(0.18)

Non-operating pension/OPEB costs - estimate

(0.05)

(0.10)

(0.39)

EPS from continuing operations (GAAP)

$1.11 - $1.21

$3.81 - $3.91

$

3.04

E.I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions, except per share amounts)

SCHEDULE D (continued)

Exchange Gains/Losses on Operating Earnings

The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in Other income, net and the related tax impact is recorded in Provision for (benefit from) income taxes on the Consolidated Income Statements.

Three Months Ended

June 30,

Six Months Ended

June 30,

2014

2013

2014

2013

Subsidiary/Affiliate Monetary Position Gain (Loss)

Pre-tax exchange gains (losses) (includes equity affiliates)

$

19

$

(55)

$

(31)

$

(150)

Local tax benefits (expenses)

(28)

16

(16)

19

Net after-tax impact from subsidiary exchange gains (losses)

$

(9)

$

(39)

$

(47)

$

(131)

Hedging Program Gain (Loss)

Pre-tax exchange gains (losses)

$

(70)

$

90

$

(116)

$

196

Tax benefits (expenses)

25

(32)

41

(69)

Net after-tax impact from hedging program exchange gains (losses)

$

(45)

$

58

$

(75)

$

127

Total Exchange Gain (Loss)

Pre-tax exchange gains (losses)

$

(51)

$

35

$

(147)

$

46

Tax benefits (expenses)

(3)

(16)

25

(50)

Net after-tax exchange gains (losses) (1)

$

(54)

$

19

$

(122)

$

(4)

As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."

(1)  The above Net after-tax exchange gains (losses) excludes gains (losses) attributable to discontinued operations of $(5) for the six months ended June 30, 2013.

Reconciliation of Base Income Tax Rate to Effective Income Tax Rate

Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), as defined above, significant items and non-operating pension/OPEB costs.

Three Months Ended

June 30,

Six Months Ended

June 30,

2014

2013

2014

2013

Income from continuing operations before income taxes

$

1,440

$

1,365

$

3,242

$

3,139

Add:   Significant items - (benefit) charge (2)

(35)

91

(19)

126

           Non-operating pension/OPEB costs

34

126

64

273

Less:  Net exchange (losses) gains

(51)

35

(147)

46

Income from continuing operations before income taxes, significant items,

    exchange gains (losses), and non-operating pension/OPEB costs

$

1,490

$

1,547

$

3,434

$

3,492

Provision for income taxes on continuing operations

$

366

$

335

$

723

$

722

Add:  Tax benefits on significant items

(27)

13

(23)

68

          Tax benefits on non-operating pension/OPEB costs

11

41

20

89

          Tax benefits on exchange gains/losses

(3)

(16)

25

(50)

Provision for income taxes on operating earnings, excluding exchange gains (losses)

$

347

$

373

$

745

$

829

Effective income tax rate

25.4

%

24.5

%

22.3

%

23.0

%

Significant items effect and non-operating pension/OPEB costs effect

(1.1)%

0.1

%

(0.4)%

1.8

%

Tax rate, from continuing operations, before significant items and non-operating pension/OPEB costs

24.3

%

24.6

%

21.9

%

24.8

%

Exchange gains (losses) effect

(1.0)%

(0.5)%

(0.2)%

(1.1)%

Base income tax rate from continuing operations

23.3

%

24.1

%

21.7

%

23.7

%

(2)  See Schedule B for detail of significant items.

 

 

SOURCE DuPont

For further information: Media Contact: Dan Turner, 302-774-4005, daniel.a.turner@dupont.com; Investor Contact: 302-774-4994

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections